BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 187785)

  • 1. Immunotherapy of cancer with nonliving mycobacteria and cord factor (trehalose-6,6'-dimycolate) in aqueous medium.
    Bekierkunst A
    J Natl Cancer Inst; 1976 Oct; 57(4):963-4. PubMed ID: 187785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy and vaccination against cancer with non-living BCG and cord factor (trehalose-6,6'-dimycolate).
    Bekierkunst A
    Int J Cancer; 1975 Sep; 16(3):442-7. PubMed ID: 170221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumor chemoimmunotherapy with mitomycin C and components from mycobacteria in regression of line 10 tumors in guinea pigs.
    McLaughlin CA; Cantrell JL; Ribi E; Goldberg EP
    Cancer Res; 1978 May; 38(5):1311-6. PubMed ID: 205361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of guinea pig cancer with BCG.
    Zbar B; Rapp HJ
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1532-40. PubMed ID: 4371315
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor regression caused by endotoxins and mycobacterial fractions.
    Ribi EE; Granger DL; Milner KC; Strain SM
    J Natl Cancer Inst; 1975 Nov; 55(5):1253-7. PubMed ID: 173865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression.
    Bekierkunst A; Wang L; Toubiana R; Lederer E
    Infect Immun; 1974 Nov; 10(5):1044-50. PubMed ID: 16558087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression and immunotherapy of the guinea pig line-10 hepatocarcinoma mediated by nonviable Staphylococcus aureus.
    Minden P; McClatchy JK; Brunda MJ
    J Natl Cancer Inst; 1978 Aug; 61(2):535-8. PubMed ID: 210295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of a guinea pig hepatoma with living BCG: a frozen liquid and a lyophilized preparation are equally active.
    Zbar B; Ribi E; Rapp HJ
    Cancer; 1977 Dec; 40(6):2930-2. PubMed ID: 201359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis.
    Zbar B; Tanaka T
    Science; 1971 Apr; 172(3980):271-3. PubMed ID: 4323415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy with nonviable microbial components.
    Ribi E; Milner KC; Granger DL; Kelly MT; Yamamoto K; Brehmer W; Parker R; Smith RF; Strain SM
    Ann N Y Acad Sci; 1976; 277(00):228-38. PubMed ID: 187099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma.
    Meyer TJ; Ribi EE; Azuma I; Zbar B
    J Natl Cancer Inst; 1974 Jan; 52(1):103-11. PubMed ID: 4359409
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression and regression of a transplanted tumor in the guinea pig colon mediated by Mycobacterium bovis, strain BCG.
    Harmel RP; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1975 Feb; 54(2):515-7. PubMed ID: 234537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of established micrometastases with Bacillus Calmette-GuĂ©rin tumor cell vaccine.
    Hanna MG; Peters LC
    Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer.
    Key ME; Brandhorst JS; Hanna MG
    J Immunol; 1983 Jun; 130(6):2987-92. PubMed ID: 6304194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma.
    Bast RC; Zbar B; Miller TE; Mackaness GB; Rapp HJ
    J Natl Cancer Inst; 1975 Mar; 54(3):757-61. PubMed ID: 164568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy with tumor cells and BCG in the guinea pig, studied by immunological in vivo and in vitro experiments.
    Rella W; Chaput B
    Oncology; 1978; 35(3):136-42. PubMed ID: 209379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment.
    Boyle MD; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1976 Mar; 56(3):623-6. PubMed ID: 176400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future prospects for immunotherapy.
    Rosenberg SA
    Cancer; 1975 Aug; 36(2):821-4. PubMed ID: 168962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete regression of a guinea pig hepatocarcinoma by immunotherapy with "tumor-immune" RNA or antibody to fibrin fragment E.
    Schlager SI; Dray S
    Isr J Med Sci; 1976; 12(4-5):344-59. PubMed ID: 181352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.